Shire Turns Attention To Vyvanse Two Years Before Adderall XL Generics
Executive Summary
Shire will seek to transition patients from Adderall XR to its next-generation attention deficit/hyperactivity disorder drug Vyvanse prior to 2009, when Adderall XR generics are expected to launch